Sector Alpha Week of 2026-08-05
Sector Alpha — machine-written from the numbers · Data as of 2026-08-05

Vital Farms, Inc.

VITL
Consumer Staples · Farm Products

Vital Farms, Inc. is cheap for a reason. The P/E sits at the 18th percentile of its own range, and the quarters are still getting worse.

The sharpest disagreement: annual EPS moved +22.0% against a −65.6% price move — the market has not yet caught up with the delivery.

The price is between stages while the P/E sits at the 18th percentile of its own 1-year range. Underneath, the last four quarters read deteriorating — profit −100.0% year on year, and 93% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.

Stage
Topping out
fundamental trajectory, 12 quarters
Price
$12.2
−65.6% 1Y
P/E
11.6×
18th pctile
of its own 1-year range
Revenue (Mar 26)
$0.2 B
+18.8% YoY
Profit (Mar 26)
$0.0 B
−100.0% YoY
Operating margin
0.0%
−12.5 pp YoY
ROE
15%
FY25
ROIC
14.7%
vs WACC 9.3% → +5.4 pp
Cash conversion
93%
of profit, last 3 FY
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Vital Farms, Inc. trades at $12.2, between stages. That is −42.6% against its own 200-day average. It sits at 9% of a 52-week range of $8 to $51. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 1 straight week.

Today the stock is between stages. At $12.2 it trades −42.6% versus its 200-day average and sits at 9% of its 52-week range ($8–$51).

Aug 26: $12.2 Weekly closing price ($) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 1-year window.
−42.6% versus the 200-day line, week — of stage —
Price50-day avg200-day avg
$54.5$42.2$29.8$17.4$5.1$$12$21Jul 25Oct 25Jan 26May 26Aug 26
$54.5$42.2$29.8$17.4$5.1$$12$21Jul 25Jan 26Aug 26
Beating or trailing, week by week since 2025 Each cell is one week from 2025 to now (57 weeks): the stock's trailing 13-week return minus the S&P 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the S&P 500 reading is not held.
trailing 13-week return vs the S&P 500
Jul 25Aug 26

Against the market, two honest reads. Cumulative: over the last 1.1 years the stock moved −68% while the S&P 500 moved +24% — behind the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 1 straight week — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.

Vital Farms, Inc. trades at 11.6× P/E, near the bottom of its own range — cheaper only 18% of the time. Its long-run median P/E is 19.8×, measured across 1.1 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 11.6× is near the bottom of its own range — cheaper only 18% of the time, against a long-run median of 19.8× measured over 1.1 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

One caveat before moving on: margins are the best this company has ever printed — cheap against its own history on record margins is not the same thing as cheap. If profitability mean-reverts, today's multiple is higher than it looks.

P/E 11.6× vs a 19.8× long-run median P/E, weekly (left axis); earnings per share, trailing twelve months, weekly step line (right axis). 1.1-year window; loss-period spikes above 46× shown pinned at the top. The eps (ttm) bars are red where the reading is lower than the quarter before.
near the bottom of its own range — cheaper only 18% of the time
P/EMedianEPS (TTM) (quarterly)
48.6×$1.637.7×$1.226.9×$0.816.0×$0.45.2×$0.0×$11.68×$1Jul 25Oct 25Jan 26May 26Aug 26
48.6×$1.637.7×$1.226.9×$0.816.0×$0.45.2×$0.0×$11.68×$1Jul 25Jan 26Aug 26
PEG 1.00 PEG ratio per quarter — the P/E divided by the earnings-growth rate. The dashed line marks 1.0: below it the growth is cheap against the multiple, above it the price already prices the growth in. Computed here as quarter-end P/E ÷ trailing-twelve-month EPS growth (only quarters with positive growth), because a reported quarterly PEG is not held for this stock. Last 9 quarters; values above 6 pinned at the top.
above 1.0, the multiple already banks the growth
PEGPEG = 1.0
6.5×4.9×3.2×1.6×0.0××1.00×Dec 23Jun 24Dec 24Jun 25Dec 25
6.5×4.9×3.2×1.6×0.0××1.00×Dec 23Dec 24Dec 25
P/E
11.6×
18th percentile of 1y
PEG
n/m
3-year earnings growth is negative

Why the multiple sits where it does: over the past year annual EPS moved +22.0% against a −65.6% price move — earnings outran the price, pushing the multiple DOWN its own range.

Put together: the multiple is low against its own past, so the story rests on the earnings line underneath it, not the multiple.

03 · Stage: Topping out

Stage: Topping out Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Vital Farms, Inc. reads as topping out on its fundamental arc. Topping out — profit and EPS growth have decelerated hard (profit growth +300.0% at its peak → +0.0% latest) while ROCE still reads 17.9%. The read is built from 12 quarters across 4 curves, on full evidence.

Growth, year by year: revenue +24.6% in FY25, profit +40.0% Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn. Turnaround-year spikes shown pinned (▲).
Revenue YoYProfit YoYEPS YoY
40%328%36%227%32%125%28%24%23%−78%%%24.6%40%FY21FY23FY25
40%328%36%227%32%125%28%24%23%−78%%%24.6%40%FY21FY23FY25
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. Base-effect spikes shown pinned (▲). A missing point means that reading is not held for the quarter.
the trajectory the stage is read from · revenue stabilising, profit rolling over
RevenueProfitEPS
45%325%38%236%32%146%25%57%18%−32%%%23.8%0%−7.1%Jun 23Sep 24Mar 26
45%325%38%236%32%146%25%57%18%−32%%%23.8%0%−7.1%Jun 23Sep 24Mar 26
ROCE Trailing-twelve-month operating profit (before interest and tax) as a share of average capital employed — total assets minus current liabilities, the standard textbook basis, %.
the return curve, computed quarterly
ROCE
25%22%18%14%11%%17.9%Jun 23Dec 23Sep 24Jun 25Mar 26
25%22%18%14%11%%17.9%Jun 23Sep 24Mar 26
Revenue growth
Steady high
latest +23.8% · span +20.0% to +43.3%
Profit growth
Falling
latest +0.0% · span +0.0% to +300.0%
EPS growth
Falling
latest −7.1% · span −7.1% to +2,800.0%
ROCE
Rolling over
latest 17.9% · span 11.8%–24.4%

Why it matters: decelerating from a peak is where good stories quietly end — the multiple usually notices late.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; stock price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+24.6%+28.3%
Profit+40.0%
EPS+22.0%+263.4%
Stock price−65.6%
Revenue YoY (Mar 26)
+18.8%
latest quarter vs a year ago
Profit YoY (Mar 26)
−100.0%
latest quarter vs a year ago
Revenue 10y
30.8%
long-run compound pace
04 · 4-Factor Sector Score

4-Factor Sector Score

41.6/100 — rank 9 of 12 in Farm Products · 75% evidence confidence

Vital Farms, Inc. scores 41.6 out of 100 against the 12 companies it is compared with in Farm Products, ranking 9. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

The four contributions add to the total exactly: 16.4 + 7.8 + 14.4 + 3 = 41.6. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

Vital Farms, Inc. reported $0.2 B of revenue in the Mar 26 quarter, +18.8% year on year. That is the 12th straight quarter of year-on-year growth. Over 4 years it has compounded at 30.8% a year. The last full year, FY25, came in at $0.8 B. The last four reported quarters add to $0.8 B.

FY25 revenue came in at $0.8 B (+24.6% on the year), capping 4 years at 30.8% compound. The latest quarter (Mar 26) printed $0.2 B, +18.8% year on year — the 12th consecutive quarter of year-over-year growth.

FY25 revenue $0.8 B (+24.6% YoY) Revenue bars, $ B (left); YoY growth-% line (right). 5-year window. A bar is red when it is lower than the year before.
30.8% a year over 4 years
RevenueYoY growth
0.840%0.636%0.432%0.228%0.023%$ B%$1B24.6%FY21FY23FY25
0.840%0.636%0.432%0.228%0.023%$ B%$1B24.6%FY21FY23FY25
Mar 26: $0.2 B (+18.8% YoY) Quarterly revenue bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
12th straight quarter of growth
Revenue (quarterly)YoY growth
0.2340%0.1731%0.1122%0.0613%0.004.2%$ B%$0B18.8%Jun 23Sep 24Mar 26
0.2340%0.1731%0.1122%0.0613%0.004.2%$ B%$0B18.8%Jun 23Sep 24Mar 26

Pace check: the last four quarters averaged +23.9% growth against the decade's 30.8% — the current year is running slower than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +23.8% over the last 4 quarters against +23.7%/yr over the last 8 — stabilising; TTM profit +0.0% vs +22.5%/yr — rolling over.

06 · Operating margin

Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

Vital Farms, Inc.'s operating margin is 0.0% in the Mar 26 quarter, −12.5 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 5 fiscal years the operating margin has ranged 0.0% to 11.8%. The current quarter sits inside that band.

The latest quarter's operating margin is 0.0%, −12.5 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 0.0%–11.8%, and FY25's 11.8% is the top of that band — a record year.

🚨 Why the margin moved: operating margin went −12.5 pp year on year while gross margin went −11.2 pp — the loss came mostly from the gross line: input costs and pricing.

Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.

FY25: 11.8% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 5-year window.
the widest a 0.0–11.8% band over 5 years
operating marginYoY change (pp)
13%6.9%9.3%5.1%5.9%3.2%2.5%1.3%−0.9%−0.5%%%11.8%2%FY21FY23FY25
13%6.9%9.3%5.1%5.9%3.2%2.5%1.3%−0.9%−0.5%%%11.8%2%FY21FY23FY25
Mar 26: 0.0% operating margin (−12.5 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
14%11%11%4.6%6.7%−1.7%2.8%−8.0%−1.1%−14%%%0%−12.5%Jun 23Sep 24Mar 26
14%11%11%4.6%6.7%−1.7%2.8%−8.0%−1.1%−14%%%0%−12.5%Jun 23Sep 24Mar 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Vital Farms, Inc. earned $0.0 B of net profit in the Mar 26 quarter, −100.0% year on year. Full-year FY25 profit was $0.1 B. That is 0.0% of the quarter's revenue. The same quarter a year earlier earned $0.0 B.

Mar 26 profit was $0.0 B, −100.0% year on year. On the full year, FY25 printed $0.1 B (+40.0%).

FY25 profit $0.1 B (+40.0% YoY) Net profit bars, $ B (left); YoY growth-% line (right). 5-year window. A bar is red when it is lower than the year before.
Net profitYoY growth
0.0869%0.0661%0.0453%0.0246%0.0038%$ B%$0B40%FY21FY23FY25
0.0869%0.0661%0.0453%0.0246%0.0038%$ B%$0B40%FY21FY23FY25
Mar 26: $0.0 B (−100.0% YoY) Quarterly net profit bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Net profit (quarterly)YoY growth
0.022116%0.01658%0.0110.0%0.005−58%0.000−116%$ B%$0B−100%Jun 23Sep 24Mar 26
0.022116%0.01658%0.0110.0%0.005−58%0.000−116%$ B%$0B−100%Jun 23Sep 24Mar 26

🚨 Why profit moved: revenue contributed +18.8% and the margin −12.5 pp — the quarter was revenue-led despite a thinner margin.

Pace comparison, last four quarters: profit +25.0% vs revenue +23.9%. Profit and revenue are moving roughly in step.

08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 3 fiscal years 93% of Vital Farms, Inc.'s reported profit arrived as operating cash — the cash follows the profit. In FY25 that was $0.0 B of operating cash against $0.1 B of profit. After $0.1 B of capital spending, $−0.1 B was left as free cash.

FY25: operating cash of $0.0 B against reported profit of $0.1 B, leaving free cash of $−0.1 B after $0.1 B of capital spending. Across the last 3 fiscal years the conversion rate is 93% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY25: CFO $0.0 B vs profit $0.1 B Operating cash flow and net profit by fiscal year, $ B; the line is free cash flow (CFO minus capital spending). 5-year window, annual resolution.
93% of 3-year profit arrived as cash
Operating cashNet profitFree cash
0.080.040.01−0.02−0.06$ B$0B$0B$−0BFY21FY23FY25
0.080.040.01−0.02−0.06$ B$0B$0B$−0BFY21FY23FY25
Mar 26: operating cash $−0.0 B Operating cash per quarter, $ B (bars); conversion = operating cash as % of net profit (line, right). Last 12 quarters. Dashed line = 100%.
Operating cash (quarterly)Conversion100%
0.02216%0.01158%0.00100%−0.0142%−0.02−16%$ B%$0B50%Jun 23Sep 24Mar 26
0.02216%0.01158%0.00100%−0.0142%−0.02−16%$ B%$0B50%Jun 23Sep 24Mar 26

Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.

Router verdict: the visible cash user is investment — the next section checks what the spending is buying.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

Vital Farms, Inc. does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $0.0 B over the last 3 years. Averaged over those years that is 0.0% of FY25 revenue a year.

Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.

On the investment side: capital spending of $0.0 B over the last 3 fiscal years.

FY25: capex $0.1 B Capital spending per fiscal year, $ B (bars).
steady investment
Capex
0.090.060.040.020.00$ B$0BFY21FY23FY25
0.090.060.040.020.00$ B$0BFY21FY23FY25
Mar 26: capex $0.0 B in the quarter Capital spending per quarter, $ B (bars, left); free cash flow, $ B (line, right). Last 12 quarters.
Capex (quarterly)Free cash
0.040.020.030.010.02−0.010.01−0.030.00−0.04$ B$ B$0B$0BJun 23Sep 24Mar 26
0.040.020.030.010.02−0.010.01−0.030.00−0.04$ B$ B$0B$0BJun 23Sep 24Mar 26

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

10 · Return on equity

Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.

Vital Farms, Inc. earns a ROE of 20% in FY25. That is up from a trough of 0% in FY21. Return on invested capital clears the cost of that capital by +5.4 percentage points, so growth here adds value rather than only size. The wiring behind it is 9.2% net margin on 1.46× asset turns.

FY25 ROE is 20%, recovered from a FY21 trough of 0% — the full ladder below shows the fall and the climb, undoctored.

Why the return is what it is — the wiring (FY25): 9.2% net margin × 1.46× asset turns × 1.49× balance-sheet leverage ≈ 20.0% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.

The capstone test — ROIC − WACC: 14.7% − 9.3% = a +5.4 pp spread. The 9.3% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. A spread this wide means every dollar reinvested creates more than a dollar of value — the engine compounds.

FY25: ROE 20% Return on equity by fiscal year, % (line); ROIC by fiscal year, % (line). 5-year window, dips included. Dashed line = the 9.3% cost of capital used on this page.
the climb back from FY21's 0%
ROEROIC (annual)WACC
48%35%22%9.3%−3.6%%20%30.6%FY21FY23FY25
48%35%22%9.3%−3.6%%20%30.6%FY21FY23FY25
Mar 26: ROIC 23.0% (TTM) vs WACC 9.3% Trailing-twelve-month ROIC and ROE, per quarter, %; dashed line = the cost of capital. Last 12 quarters, put on a trailing-twelve-month basis and anchored to the annual figure.
ROIC (TTM)ROE (TTM)WACC
51%40%29%17%6.2%%23%16.5%Jun 23Sep 24Mar 26
51%40%29%17%6.2%%23%16.5%Jun 23Sep 24Mar 26
11 · Dividend

Dividend

Vital Farms, Inc. pays no dividend. Across the last 12 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.

Vital Farms, Inc. does not currently pay a dividend. Across the last 12 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.

12 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.

Vital Farms, Inc. carries total debt of $0.1 B against shareholder equity of $0.3 B as of Mar 26, a debt-to-equity of 0.15 — effectively unlevered. On the annual view that ratio went from 0.00 in FY21 to 0.14 in FY25. The returns elsewhere on this page are therefore earned rather than borrowed.

Mar 26: total debt of $0.1 B against shareholder equity of $0.3 B — a debt-to-equity of 0.15. On the annual view, debt-to-equity went from 0.00 (FY21) to 0.14 (FY25). The returns on this page are earned, not borrowed.

FY25: debt $0.1 B at 0.14× equity Total debt by fiscal year, $ B (bars); debt-to-equity, × (line). 5-year window.
Total debtDebt-to-equity
0.050.15×0.040.11×0.030.07×0.010.03×0.00−0.01×$ B×$0B0.14×FY21FY23FY25
0.050.15×0.040.11×0.030.07×0.010.03×0.00−0.01×$ B×$0B0.14×FY21FY23FY25
Mar 26: debt $0.1 B, debt-to-equity 0.15 Total debt per quarter, $ B (bars); debt-to-equity, × (line). Last 12 quarters.
Total debt (quarterly)Debt-to-equity
0.060.19×0.050.15×0.030.12×0.020.09×0.000.05×$ B×$0B0.15×Jun 23Sep 24Mar 26
0.060.19×0.050.15×0.030.12×0.020.09×0.000.05×$ B×$0B0.15×Jun 23Sep 24Mar 26
13 · Ownership

Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.

23.2% of Vital Farms, Inc.'s tradable float is currently sold short — a large bloc is positioned against it. At typical trading volumes those positions would take about 3.4 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.

The latest reading: 23.2% of the float is sold short, and at typical trading volumes it would take about 3.4 days to buy those positions back. A large bloc is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.

Short interest
23.2%
of the tradable float
Days to cover
3.4
at typical volumes

Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.

14 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Vital Farms, Inc.: the Z-score reads 8.34. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits well clear of distress. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.

Why it matters: a Z-score of 8.34 sits well clear of the distress zone — the balance sheet is not the risk here.

The safety line in one sentence: the Z-score reads 8.34.

15 · Related companies · Farm Products
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Archer-Daniels-Midland CompanyADM 60.1/100Mixed-positive evidence81% evidence ASLEEP 17.6/35 Revenue -3.9% · PAT -19.8% · OPM change 0.5 pp 83% evidence 12.6/25 ROCE 1% · OPM 1.6% 76% evidence 14.4/20 P/E 32.6× · PEG 0.52 65% evidence 15.5/20 RS sector 21.4% · RS bench 5.3% · 1Y 38.1%5 of 12 weeks ahead 100% evidence
Exact sum: 17.6 + 12.6 + 14.4 + 15.5 = 60.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
2Bunge Global SABG 54.2/100Thin evidence · provisional58% evidence ASLEEP 19.2/35 Revenue — · PAT — · OPM change -0.8 pp 45% evidence 14.4/25 ROCE 4.3% · OPM 1.1% 76% evidence 10.3/20 P/E 20.6× · PEG — 15% evidence 10.3/20 RS sector 4.2% · RS bench -9.9% · 1Y 28.7%0 of 12 weeks ahead 100% evidence
Exact sum: 19.2 + 14.4 + 10.3 + 10.3 = 54.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
3Village Farms International, Inc.VFF 52.8/100Thin evidence · provisional58% evidence BASING 22.0/35 Revenue 17% · PAT — · OPM change 0.9 pp 62% evidence 15.5/25 ROCE 10.9% · OPM 73.5% 76% evidence 11.5/20 P/E 8.1× · PEG — 15% evidence 3.8/20 RS sector -28.6% · RS bench -38.9% · 1Y 15.7%0 of 12 weeks ahead 70% evidence
Exact sum: 22 + 15.5 + 11.5 + 3.8 = 52.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
4Dole plcDOLE 51.8/100Mixed-positive evidence75% evidence BASING 16.1/35 Revenue 11.4% · PAT -25.4% · OPM change -0.6 pp 83% evidence 12.8/25 ROCE 2.1% · OPM 2.6% 76% evidence 14.7/20 P/E 31.8× · PEG 0.22 65% evidence 8.2/20 RS sector 0.8% · RS bench -13.1% · 1Y -4.3%0 of 12 weeks ahead 70% evidence
Exact sum: 16.1 + 12.8 + 14.7 + 8.2 = 51.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
5Tyson Foods, Inc.TSN 48.4/100Mixed-negative evidence71% evidence BASING 18.1/35 Revenue 3.9% · PAT -48.8% · OPM change 2.4 pp 83% evidence 12.7/25 ROCE 1.4% · OPM 3.2% 76% evidence 9.1/20 P/E 49.9× · PEG — 15% evidence 8.5/20 RS sector 3.5% · RS bench -10.7% · 1Y 3%0 of 12 weeks ahead 100% evidence
Exact sum: 18.1 + 12.7 + 9.1 + 8.5 = 48.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
6Alico, Inc.ALCO 47.2/100Thin evidence · provisional58% evidence ASLEEP 20.4/35 Revenue -68% · PAT — · OPM change 704.9 pp 62% evidence 4.3/25 ROCE -3.6% · OPM -146.5% 76% evidence 10.0/20 P/E 30.7× · PEG — 15% evidence 12.5/20 RS sector 4% · RS bench -10.1% · 1Y 18.8%0 of 12 weeks ahead 70% evidence
Exact sum: 20.4 + 4.3 + 10 + 12.5 = 47.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
7Adecoagro S.A.AGRO 46.8/100Mixed-negative evidence75% evidence BASING 15.7/35 Revenue -4.1% · PAT -71.9% · OPM change 4.4 pp 83% evidence 12.2/25 ROCE 0.6% · OPM 5.4% 76% evidence 13.3/20 P/E 883.5× · PEG 0.78 65% evidence 5.6/20 RS sector -2.1% · RS bench -15.3% · 1Y 1.2%2 of 12 weeks ahead 70% evidence
Exact sum: 15.7 + 12.2 + 13.3 + 5.6 = 46.8 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
8Cal-Maine Foods, Inc.CALM 44.8/100Thin evidence · provisional58% evidence BREAKING OUT 11.9/35 Revenue — · PAT — · OPM change -39.4 pp 45% evidence 9.4/25 ROCE -2.1% · OPM 5.4% 76% evidence 11.2/20 P/E 11.3× · PEG — 15% evidence 12.3/20 RS sector 1.8% · RS bench -12.5% · 1Y -21.3%5 of 12 weeks ahead 100% evidence
Exact sum: 11.9 + 9.4 + 11.2 + 12.3 = 44.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
9Vital Farms, Inc.this pageVITL 41.6/100Mixed-negative evidence75% evidence TURNING 16.4/35 Revenue 26.6% · PAT -7.8% · OPM change -14.6 pp 83% evidence 7.8/25 ROCE -0.7% · OPM -1.2% 76% evidence 14.4/20 P/E 12.6× · PEG 1 65% evidence 3.0/20 RS sector -50.7% · RS bench -58.3% · 1Y -73.3%2 of 12 weeks ahead 70% evidence
Exact sum: 16.4 + 7.8 + 14.4 + 3 = 41.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
10BrasilAgro - Companhia Brasileira de Propriedades AgrícolasLND 35.8/100Thin evidence · provisional58% evidence BASING 10.6/35 Revenue -26.3% · PAT -104.5% · OPM change -16.8 pp 62% evidence 8.0/25 ROCE -0.3% · OPM -5.1% 76% evidence 10.6/20 P/E 15.1× · PEG — 15% evidence 6.6/20 RS sector -1.4% · RS bench -15.1% · 1Y -5%0 of 12 weeks ahead 70% evidence
Exact sum: 10.6 + 8 + 10.6 + 6.6 = 35.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
11Limoneira CompanyLMNR 29.8/100Adverse evidence61% evidence TURNING 7.4/35 Revenue -25% · PAT — · OPM change -81.2 pp 71% evidence 3.5/25 ROCE -8.1% · OPM -90.7% 76% evidence 8.8/20 P/E 56.2× · PEG — 15% evidence 10.1/20 RS sector 1.8% · RS bench -12.4% · 1Y -12.2%0 of 12 weeks ahead 70% evidence
Exact sum: 7.4 + 3.5 + 8.8 + 10.1 = 29.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
12Forafric Global PLCAFRI 51.4/100Thin evidence · provisional29% evidence ASLEEP 18.1/35 Revenue — · PAT — · OPM change — 9% evidence 8.6/25 ROCE -0.7% · OPM — 46% evidence 10.0/20 P/E — · PEG — 0% evidence 14.7/20 RS sector 11.7% · RS bench -3.4% · 1Y 35.7%1 of 12 weeks ahead 70% evidence
Exact sum: 18.1 + 8.6 + 10 + 14.7 = 51.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

16 · Frequently asked questions

Frequently asked questions

What is Vital Farms, Inc.'s stock price today?

Vital Farms, Inc. trades at $12.2, −65.6% over the past year. The company is valued at $1.0 B. The stock sits at 9% of its 52-week range of $8–$51, −42.6% versus its 200-day average. Against the S&P 500 it has been ahead on a trailing-13-week view for 1 week. — as of 5 August 2026.

What were Vital Farms, Inc.'s latest quarterly results?

Vital Farms, Inc. reported revenue of $0.2 B and net profit of $0.0 B for the Mar 26 quarter. Revenue rose 18.8% and profit fell 100.0% year on year. The operating margin was 0.0%, 12.5 pp lower than a year earlier. — as of 5 August 2026.

What is Vital Farms, Inc.'s revenue?

Vital Farms, Inc. reported revenue of $0.2 B in the Mar 26 quarter, +18.8% year on year. For the full FY25 fiscal year, revenue was $0.8 B (+24.6%). Over the last 4 years revenue compounded at 30.8% a year. — as of 5 August 2026.

What is Vital Farms, Inc.'s profit?

Vital Farms, Inc. earned $0.0 B of net profit in the Mar 26 quarter, −100.0% year on year. Full-year FY25 profit was $0.1 B. The operating margin ran 0.0% in the latest quarter. — as of 5 August 2026.

What is Vital Farms, Inc.'s market cap?

Vital Farms, Inc.'s market capitalisation is $1.0 B at a stock price of $12.2. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.

What is Vital Farms, Inc.'s P/E ratio?

Vital Farms, Inc. trades at a P/E of 11.6×, at the 18th percentile of its own 1-year range, against a long-run median of 19.8×. This is a comparison with the stock's own history, not a value call — as of 5 August 2026.

Does Vital Farms, Inc. pay a dividend?

No — Vital Farms, Inc. has declared no dividend per share in any of its last 12 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 5 August 2026.

Is Vital Farms, Inc. overvalued?

On its own history, Vital Farms, Inc. looks cheap against its own history: its P/E of 11.6× has been cheaper only 18% of the time in 1 years (long-run median 19.8×). That is a percentile read against the stock's own past, not a price opinion or a direction call. One caveat: margins are the best this company has ever printed — cheap on record margins is not the same thing as cheap. — as of 5 August 2026.

Is Vital Farms, Inc. growing?

Not right now — Vital Farms, Inc.'s latest numbers are shrinking: latest-quarter revenue +18.8% year on year, profit −100.0%, and the margin −12.5 pp at 0.0%. The earnings engine currently reads: deteriorating — as of 5 August 2026.

How is Vital Farms, Inc. performing?

Vital Farms, Inc.'s latest readings are below. Its latest quarter's revenue rose 18.8% and profit fell 100.0% year on year. Against the S&P 500 it has been ahead on a trailing-13-week view for 1 week. This describes what the data did, not a rating. — as of 5 August 2026.

What stage is Vital Farms, Inc. in?

Topping out — profit and EPS growth have decelerated hard (profit growth +300.0% at its peak → +0.0% latest) while ROCE still reads 17.9%. The read comes from the last 12 quarters of growth (revenue growth +23.8% latest, profit growth +0.0% latest, eps growth −7.1% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 5 August 2026.

Is Vital Farms, Inc. beating the market?

On recent form, yes — Vital Farms, Inc. has been ahead of the S&P 500 on a trailing-13-week view for 1 straight week, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 1.1 years the stock moved −68% against the S&P 500's +24% — behind the index over the full window. — as of 5 August 2026.

Will Vital Farms, Inc.'s stock price go up?

This page publishes no price forecast for Vital Farms, Inc. What it measures instead: the stock price is $12.2. Its P/E of 11.6× sits at the 18th percentile of its own 1-year range. Direction is not something this site claims to know. — as of 5 August 2026.

Is the market betting against Vital Farms, Inc.?

Yes — short interest is 23.2% of Vital Farms, Inc.'s tradable float, about 3.4 days to cover at typical volumes. A crowded short: a large bloc is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 5 August 2026.

Does Vital Farms, Inc. have too much debt?

No — Vital Farms, Inc.'s debt-to-equity is 0.16. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. The returns on this page are earned, not borrowed — as of 5 August 2026.

What is Vital Farms, Inc.'s capex?

Vital Farms, Inc. spent $0.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $0.1 B. — as of 5 August 2026.

What is Vital Farms, Inc.'s cash flow?

Vital Farms, Inc. generated $0.0 B of operating cash flow in FY25 and $−0.1 B of free cash flow after $0.1 B of capital spending. Reported profit that year was $0.1 B, so operating cash ran behind profit. — as of 5 August 2026.

Is Vital Farms, Inc.'s profit real cash?

Yes — over the last 3 fiscal years, 93% of Vital Farms, Inc.'s reported profit arrived as operating cash. In FY25, operating cash was $0.0 B against reported profit of $0.1 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 5 August 2026.

How financially safe is Vital Farms, Inc.?

On the balance sheet, the Z-score reads 8.34 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That sits well clear of trouble. — as of 5 August 2026.

Where is Vital Farms, Inc. in its business cycle?

Vital Farms, Inc.'s FY25 operating margin was 11.8%, against a 5-year band of 0.0%–11.8%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran 0.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.

What could break the Vital Farms, Inc. story?

The sharpest disagreement: annual EPS moved +22.0% against a −65.6% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.

Is Vital Farms, Inc. a stock worth studying right now?

This is not investment advice. The machine read: Vital Farms, Inc. is cheap for a reason. The P/E sits at the 18th percentile of its own range, and the quarters are still getting worse. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI